Elevated expression of HIF-1α and the loss of prolyl hydroxylase enzyme 3 (PHD3) and factor inhibiting HIF (FIH) in the nucleus have been observed in 125 BRCA-associated breast cancers [41]. Here, CASR is linked to breast carcinoma.